AZN Related
-
Form 6-K ASTRAZENECA PLC For: May 08
-
Optimer Pharmaceuticals (OPTR) Jumps as AstraZeneca (AZN), Cubist (CBST) Submit First Round Bids
-
Assessing Your Asthma is Key to Taking Control
-
Form 6-K ASTRAZENECA PLC For: May 08
-
Form 6-K ASTRAZENECA PLC For: May 08
-
Former AstraZeneca N.A. CEO to Serve as Senior Advisor to VIVUS (VVUS)
-
Sub-Group Analysis Shows Investigational Metreleptin Treatment Demonstrated Reductions in HbA1c, Triglycerides and Liver Function Tests in Pediatric Patients with Lipodystrophy During a 12-Month Perio
-
MedImmune To Present Seven Posters On Influenza, Respiratory Syncytial Virus At The Annual Pediatric Academic Societies Meeting
-
Form 6-K ASTRAZENECA PLC For: May 02
-
Form 6-K ASTRAZENECA PLC For: May 01
-
Form 6-K ASTRAZENECA PLC For: May 01
-
Form 6-K ASTRAZENECA PLC For: Apr 29
-
Form 6-K ASTRAZENECA PLC For: Apr 29
-
Form 6-K ASTRAZENECA PLC For: Apr 25
-
Form 6-K ASTRAZENECA PLC For: Apr 25
-
Form 6-K ASTRAZENECA PLC For: Apr 23
-
Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)
-
MedImmune to Exhibit at 2013 BIO International Convention, booth 3344, Apr 22 - 25, 2013, in Chicago IL, US
-
Streetinsider.com Pre-Open Movers 04/05: (XIDE) (NIHD) (NVAX) Higher; (RIGL) (FFIV) (SABA) Lower
-
Form 6-K ASTRAZENECA PLC For: Apr 05
-
AstraZeneca (AZN) Reports Statistically Significant Data from OSKIRA-1
-
Form 6-K ASTRAZENECA PLC For: Apr 03
-
Form 6-K ASTRAZENECA PLC For: Apr 03
-
Dupilumab Could End of Being 'Blockbuster' Asthma Drug - Analyst (SNY) (REGN)
-
Actavis (ACT) Receives Favorable Verdict in Generic Pulmicort Respules Patent Case
-
Actavis (ACT) Receives TRO on Sales of Pulmicort Respules
-
Form 6-K ASTRAZENECA PLC For: Apr 02
-
AstraZeneca (AZN) May Appeal Adverse Pulmicort Respules Litigation Verdict
-
Optimer Pharma (OPTR) Said to Draw Interest from Glaxo (GSK), Astellas
-
Form 6-K ASTRAZENECA PLC For: Apr 02
-
JPMorgan Upgrades AstraZeneca (AZN) to Neutral
-
Form 6-K ASTRAZENECA PLC For: Apr 02
-
Amarin's (AMRN) Vascepa Tracking Well 3-Months In; Investors Eye Tier 2 Designation
-
Form 6-K ASTRAZENECA PLC For: Mar 27
-
Form 6-K ASTRAZENECA PLC For: Mar 27
-
Form 6-K ASTRAZENECA PLC For: Mar 26
-
Form 6-K ASTRAZENECA PLC For: Mar 26
-
Form 6-K ASTRAZENECA PLC For: Mar 26
-
Form 6-K ASTRAZENECA PLC For: Mar 25
-
Form 6-K ASTRAZENECA PLC For: Mar 25
-
Natixis Upgrades AstraZeneca (AZN) to Neutral
-
AstraZeneca (AZN) Updates on Growth Strategies; Plans tor Headcount Reduction
-
Form 6-K ASTRAZENECA PLC For: Mar 20
-
Form 6-K ASTRAZENECA PLC For: Mar 20
-
AstraZeneca (AZN) Enters RNA Agreement with Moderna Therapeutics
-
Form 6-K ASTRAZENECA PLC For: Mar 20
-
AstraZeneca (AZN) to Relocate R&D Center; Sees $1.4B in One-Time Charges
-
Targacept (TRGT) Enters New Modulator Collaboration Agreement w/ AstraZeneca (AZN)
-
AstraZeneca (AZN) Issues Encouraging Update from High-Level KODIAC-08 Trial
-
AstraZeneca's (AZN) Best Chance to Regain Profitability? One Major Acquisition...
Back to AZN Stock Lookup
